Fig. 1From: Kv1.3 channel blocker (ImKTx88) maintains blood–brain barrier in experimental autoimmune encephalomyelitisImKTx88 ameliorates inflammation and demyelination in EAE rats. a HE and LFB staining of cerebellum sections demonstrated inflammation and demyelination on day 21 after EAE induction. The scale bar represents 100 µm; b the inflammation score and c demyelination score were evaluated. Data represent the mean ± SEM, *P < 0.05, **P < 0.01Back to article page